{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:32:08Z","timestamp":1780050728204,"version":"3.53.1"},"reference-count":10,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nucl Med"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/0972-3919.202239","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T11:50:19Z","timestamp":1489665019000},"page":"140","source":"Crossref","is-referenced-by-count":7,"title":["Image findings of rare case of peritoneal carcinomatosis from non small cell lung cancer and response to erlotinib in F-18 FDG positron emission tomography\/computed tomography"],"prefix":"10.25259","volume":"32","author":[{"given":"KoramadaiKaruppusamy","family":"Kamaleshwaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jephy","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhakrishnan","family":"Kalarikal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AjitSugunan","family":"Shinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0972-3919.202239-1","first-page":"69","volume-title":"Global cancer statistics","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key-10.4103\/0972-3919.202239-2","first-page":"308","volume-title":"et al. Omental metastases from primary lung adenocarcinoma","author":"Loannidis","year":"2012","journal-title":"Rev Invest Clin"},{"key":"key-10.4103\/0972-3919.202239-3","first-page":"123","volume-title":"et al. Erlotinib in previously treated non-small-cell lung cancer","author":"Shepherd","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0972-3919.202239-4","first-page":"1684","volume-title":"et al. 18F-FDG PET\/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib","author":"Benz","year":"2011","journal-title":"J Nucl Med"},{"key":"key-10.4103\/0972-3919.202239-5","first-page":"1305","volume-title":"Peritoneal carcinomatosis in lung cancer patients","author":"Satoh","year":"2001","journal-title":"Oncol Rep"},{"key":"key-10.4103\/0972-3919.202239-6","first-page":"465","volume-title":"Perng RP: Peritoneal carcinomatosis in lung cancer","author":"Su","year":"2008","journal-title":"Respirology"},{"key":"key-10.4103\/0972-3919.202239-7","first-page":"319","volume-title":"et al. Gastro-intestinal metastasis of primary lung carcinoma: clinical presentations and outcome","author":"Yang","year":"2006","journal-title":"Lung Cancer"},{"key":"key-10.4103\/0972-3919.202239-8","first-page":"521","volume-title":"Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study","author":"Cappuzzo","year":"2010","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0972-3919.202239-9","first-page":"1344","volume-title":"Is 18F-FDG PET\/CT useful for the early prediction of histopathologic response to neoadjuvant erlotinib in patients with non-small cell lung cancer?","author":"Aukema","year":"2010","journal-title":"J Nucl Med"},{"key":"key-10.4103\/0972-3919.202239-10","first-page":"1701","volume-title":"Early prediction of non progression in advanced non-small-cell lung cancer treated with erlotinib by using [18F] fluorodeoxyglucose and [18F] fluorothymidine positron emission tomography","author":"Zander","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Indian Journal of Nuclear Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:34:29Z","timestamp":1779694469000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijnm.co.in\/image-findings-of-rare-case-of-peritoneal-carcinomatosis-from-non-small-cell-lung-cancer-and-response-to-erlotinib-in-f-18-fdg-positron-emission-tomography-computed-tomography\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"alternative-id":["202239"],"URL":"https:\/\/doi.org\/10.4103\/0972-3919.202239","relation":{},"ISSN":["0972-3919"],"issn-type":[{"value":"0972-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}